Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Glaxosmithkline Pharmaceuticals LtdIndustry : Pharmaceuticals - Multinational
BSE Code:500660NSE Symbol: GLAXOP/E(TTM):65.69
ISIN Demat:INE159A01016Div & Yield %:1.27EPS(TTM):38.44
Book Value(Rs):105.3146687Market Cap ( Cr.):42778.41Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 3407.253216.343217.512920.483224.683128.53
Excise Duty0.000.000.000.000.000.00
Net Sales3407.253216.343217.512920.483224.683128.53
Other Income 143.17114.961423.27217.71624.37149.56
Stock Adjustments 69.64-67.25-13.8326.1235.43-25.57
Total Income3620.063264.054626.953164.313884.483252.52
EXPENDITURE :      
Raw Materials 1358.071182.781281.911275.491343.301327.96
Power & Fuel Cost29.6429.6027.8326.0833.3627.94
Employee Cost 624.39594.99610.23616.16628.55537.20
Other Manufacturing Expenses 113.6199.05120.14110.59107.88115.19
Selling and Administration Expenses 374.71370.30343.57242.00376.68381.32
Miscellaneous Expenses 239.1284.3285.69287.75983.19150.08
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure2739.542361.042469.382558.073472.962539.68
Operating Profit880.52903.012157.57606.24411.52712.85
Interest 1.801.811.993.536.340.55
Gross Profit878.72901.202155.58602.71405.18712.30
Depreciation69.6865.7768.1978.6082.6848.59
Profit Before Tax809.04835.432087.39524.11322.50663.71
Tax235.71246.05407.36158.67260.17192.82
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-11.36-18.37-10.497.87-47.7245.52
Reported Net Profit584.69607.751690.53357.57110.05425.36
Extraordinary Items -66.5821.0511.18-117.79-87.094.04
Adjusted Net Profit651.27586.701679.35475.36197.14421.32
Adjst. below Net Profit -21.25-17.08-11.050.00-73.62-64.12
P & L Balance brought forward828.121745.02562.71882.771177.991113.21
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 542.101524.66508.22677.62338.81296.46
P & L Balance carried down849.46811.031733.98562.71875.621177.99
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %320.00320.00900.00300.00400.00200.00
Earnings Per Share-Unit Curr34.5135.8899.7921.116.5025.11
Earnings Per Share(Adj)-Unit Curr34.5135.8899.7921.116.5025.11
Book Value-Unit Curr105.31103.48158.0688.37108.62126.47